Longevity Life Sciences Overview
Founders & Establishment:
Longevity Life Sciences was co-founded in 2023 by Sally Panton (CEO) and Lucy Canny (COO). The company aims to enhance cellular health through science-backed ingredients.
Awards & Recognition:
In 2026, the Australia-based company won the Start-up of the Year at the NutraIngredients-Asia Awards, outperforming competitors like HiveEnergy Sports Gel and Taama.
Pioneering Approval & Product Offerings
Regulatory Milestone:
Longevity Life Sciences made history as the first company in Australia to receive Therapeutic Goods Administration (TGA) approval for Nicotinamide Mononucleotide (NMN) sourced from SyzncoZymes in Shanghai. This approval allowed the ingredient to be marketed in dietary supplements with claims such as reducing free radicals and supporting energy production.
Commercial Success:
Since its launch in December 2025, about 40 Australian brands, including Melrose, Swisse, and Bioglan, have incorporated the CellVive NMN ingredient. The firm has generated approximately $16 million in revenue, selling over 2.4 million products containing CellVive NMN.
Future Plans & Ingredient Expansions
Partnerships & New Products:
Longevity Life Sciences is collaborating with Mitsubishi Gas Chemical (MGC) to introduce additional cellular health compounds, starting with Pyrroloquinoline Quinone (PQQ), branded as BioPQQ. This ingredient aims to support cellular energy, brain health, and new mitochondria growth.
Clinical Trials:
The company has initiated a multi-year partnership with the University of Sydney to conduct significant clinical trials on NMN, planning to study the health impacts on a large participant base.
Global Expansion
Market Entry Plans:
Longevity Life Sciences seeks to expand into Southeast Asian markets, including Thailand, Malaysia, Singapore, and Vietnam, where there is high demand for CellVive NMN. Pursuing regulatory pathways in these regions is a priority, particularly in Thailand.
Chinese Market Opportunity:
The company is exploring opportunities to introduce its products into the Chinese market, especially through cross-border e-commerce (CBEC), following TGA approval.
Foundational Experience
Background of Founders:
Before creating Longevity Life Sciences, co-founders Panton and Canny worked at Pantonic Health, focusing on preventative health diagnostics. Their expertise in navigating regulatory frameworks has been pivotal in establishing the new venture, filling a gap in the market for approved cellular health ingredients.
